Cytosorbents Corporation
CTSO
$0.59
$0.000.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.25M | 7.54M | 10.20M | 11.59M | 3.28M |
| Total Receivables | 7.55M | 7.43M | 7.74M | 7.67M | 7.32M |
| Inventory | 5.28M | 4.00M | 3.71M | 3.02M | 2.73M |
| Prepaid Expenses | 1.55M | 2.35M | 1.33M | 3.14M | 3.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 5.00M |
| Total Current Assets | 20.63M | 21.31M | 22.99M | 25.41M | 21.60M |
|
|
|||||
| Total Current Assets | 20.63M | 21.31M | 22.99M | 25.41M | 21.60M |
| Net Property, Plant & Equipment | 18.75M | 19.27M | 19.69M | 20.09M | 20.51M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.23M | 3.59M | 3.74M | 3.70M | 3.72M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.58M | 1.58M | 1.58M | 1.57M | 1.53M |
| Total Assets | 44.18M | 45.75M | 47.99M | 50.78M | 47.37M |
|
|
|||||
| Total Accounts Payable | 2.87M | 3.04M | 3.39M | 3.33M | 3.34M |
| Total Accrued Expenses | 5.06M | 6.15M | 4.61M | 4.45M | 4.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 541.00K | 518.00K | 495.00K | 473.90K | 453.00K |
| Total Finance Division Other Current Liabilities | 1.24M | 409.00K | 1.35M | 1.49M | 1.32M |
| Total Other Current Liabilities | 1.24M | 409.00K | 1.35M | 1.49M | 1.32M |
| Total Current Liabilities | 9.71M | 10.11M | 9.84M | 9.74M | 9.83M |
|
|
|||||
| Total Current Liabilities | 9.71M | 10.11M | 9.84M | 9.74M | 9.83M |
| Long-Term Debt | 16.67M | 14.57M | 14.38M | 14.19M | 14.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.90M | 12.05M | 12.19M | 12.32M | 12.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.28M | 36.73M | 36.40M | 36.24M | 36.27M |
|
|
|||||
| Common Stock & APIC | 321.09M | 319.57M | 319.09M | 318.51M | 310.86M |
| Retained Earnings | -312.21M | -306.71M | -303.54M | -305.49M | -304.01M |
| Treasury Stock & Other | -2.98M | -3.84M | -3.96M | 1.52M | 4.25M |
| Total Common Equity | 5.90M | 9.02M | 11.59M | 14.54M | 11.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.90M | 9.02M | 11.59M | 14.54M | 11.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.90M | 9.02M | 11.59M | 14.54M | 11.11M |
|
|
|||||